Commentary: New strategies for old techniques

Ramadan and colleagues1 have outlined a reliable method for testing the impact of varying concentrations of oxaliplatin with in  vivo lung perfusion (IVLP). This group has pioneered ex vivo lung perfusion for treatment of donor lungs for transplant. Now, they have added the effort to treat the lung in vivo for cancer.

Source: The Journal of Thoracic and Cardiovascular Surgery - May 3, 2020 Category: Cardiovascular & Thoracic Surgery Authors: Philip W. Carrott, R. Taylor Ripley Tags: Commentary Source Type: research